La description :skip to content skip to search australia (en) select a region africa algeria (en) kenya (en) morocco (en) nigeria (en) south africa (en) tunisia (en) asia & the middle east armenia (en) azerbaijan...
Classement Alexa Global: # 2,918,688
L'adresse IP principale: 34.196.46.215,Votre serveur United States,Houston
ISP:Halliburton Company TLD:au Code postal:us
Ce rapport est mis à jour en 26-Jul-2018
Changed Date:
2018-01-02
Données techniques du gsk.com.au
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte gsk.com.au.Actuellement, hébergé dans United States et son fournisseur de services est Halliburton Company .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
Content-Length:
21292
X-XSS-Protection:
1; mode=block
X-Content-Type-Options:
nosniff
Content-Encoding:
gzip
Set-Cookie:
AWSALB=Osc1h7YtTqVQegPBA+h4jzJWotcEU0NoUUcbpMec5rglvqiapOPX0WDIbS4VZKs0347l9lISXeeHBWDwPTKAfF7RNmXXjizrbYgqkTX2jRWlmXqqrBBKdZ+9prCq; Expires=Thu, 02 Aug 2018 04:17:33 GMT; Path=/
IP:34.196.46.215 ASN:14618 OWNER:AMAZON-AES - Amazon.com, Inc., US Country:US IP:52.20.209.186 ASN:14618 OWNER:AMAZON-AES - Amazon.com, Inc., US Country:US
mx:
MX preference = 10, mail exchanger = mailaws.imgw.com.
HtmlToText
skip to content skip to search australia (en) select a region africa algeria (en) kenya (en) morocco (en) nigeria (en) south africa (en) tunisia (en) asia & the middle east armenia (en) azerbaijan (en) bangladesh (en) cambodia (en) china (zh/en) egypt (en/ar) georgia (en) hong kong (en/zh) india (en) indonesia (en/id) israel (en) japan (jp) kazakhstan (ru) korea (ko) malaysia (en) myanmar (en) pakistan (en/ur) philippines (en) saudi arabia (en) singapore (en) sri lanka (en) taiwan (zh) thailand (en) turkey (tr) united arab emirates (en) uzbekistan (en) vietnam (vi/en) australasia australia (en) new zealand (en) europe albania (en) austria (de) belarus (en) belgium (fr/nl/en) bosnia and herzegovina (en) bulgaria (bg) croatia (hr) cyprus (en) czech republic (cs) denmark (da) estonia (et) finland (fi) france (fr) germany (de) greece (el) hungary (hu) ireland (en) italy (it) latvia (en) lithuania (en) luxembourg (fr/nl/en) macedonia (en) malta (en) moldova (en) netherlands (nl) norway (nb) poland (pl) portugal (pt) romania (ro) russia (ru) serbia (sr) slovakia (sk) slovenia (sl) spain (es) sweden (sv) switzerland (de/fr) ukraine (uk) united kingdom (en) north america canada (en/fr) mexico (en) united states (en) south & central america argentina (es) brazil (pt) caribbean islands (en) chile (en) colombia (en/es) costa rica (en) dominican republic (en) ecuador (en) el salvador (en) guatemala (en) honduras (en) jamaica (en) panama (en/es) peru (en) trinidad & tobago (en) uruguay (en) venezuela (en) gsk global website www.gsk.com search consumers healthcare professionals healthcare professionals interactions with prescribers collaborating on clinical trials and research transparency disclosures transparency disclosures 2015 2014 2013 2012 2011 2010 transfer of value reports transfer of value reports reporting periods media media press releases resource centre resource centre malaria bioelectronics if there are no scientists, who will cure diseases? supply updates contact us contact us our locations media professionals menu behind the science behind the science tags a-z access to healthcare access to healthcare a rapid response to slow acting disasters the fight against malaria increasing medicine access across the world's poorest nations no 'silver bullet' to tackle this disease giving babies a healthier start international collaboration seeks to make childbirth safer in developing countries malaria understanding of copd improved through gsk supported independent medical education program innovation innovation australian innovation pilot aims to reduce cost of vaccination in developing world innovation and collaboration with monash university bioelectronics investing in our future our people our people mark lambert annette gross laura ljubanovic rachael’s trek for kids lisa bonadonna isaac barr philip leslie rachael's trek for kids environment environment trusted partnership achieves supply chain improvements reducing our carbon footprint everyday health everyday health keep moving - jan's story every breathe you take: alannah's story living with copd: peter's story digital healthcare attitudes in australia living every day with copd our community our community polio australia - support of polio retreat to help those affected victoria police - trek of a lifetime nysf - inspiring the next generation of scientists keeping our olympic athletes healthy and ready to compete in rio volunteering in kenya play-based learning for australian kids save the children employees helping communities a comic book on vaccines how we do business how we do business fostering excellence in respiratory research crowd sourcing new treatments for malaria harnessing the electrical language of the body to treat disease open source: the future of medical discovery pharmaus 2017: showcasing the health and economic benefits of innovation in medicines pulling back the curtain on the pbs about us about us what we do what we do pharmaceuticals vaccines consumer healthcare our history our mission and strategy partnerships partnerships monash university save the children policies, codes and standards policies, codes and standards gsk industry media mentions what we do we are a science-led global healthcare company. we research and develop a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. our mission and strategy our mission is to help people do more, feel better and live longer. partnerships we know that many of the best ideas can come from outside of gsk, and collaborating with other companies, organizations, nonprofits/ngos, and academics is a fundamental part of our business strategy. policies, codes and standards we believe how we deliver is just as important as what we deliver. our history find out about the many products and mergers that led to the gsk we know today. media mentions we often feature in the australian media. find out about our recent media coverage. products products our prescription medicines and vaccines our consumer healthcare products viiv healthcare stiefel dermatology our consumer healthcare products we invest in building brands that consumers trust and come back to, time and time again. our prescription medicines and vaccines we produce treatments for a wide range of conditions as well as more than 30 vaccines worldwide. viiv healthcare viiv healthcare is a global specialist hiv company dedicated to delivering advances in treatment and care for people living with hiv. stiefel dermatology stiefel is a global leader in the field of dermatology and is renowned for its expertise in acne, psoriasis, eczema, atopic dermatitis and superficial skin infections. careers careers search jobs and apply application tips working at gsk working at gsk employee volunteering volunteer story - alicia cook students graduates apprenticeships apprenticeships manufacturing and process industry electrical apprenticeship manufacturing and process industry mechanical apprenticeship development and benefits application and assessment parents and teachers maintenance electrician - adam meet our people search jobs and apply search for jobs and graduate positions across the world of gsk. application tips you're ready to apply. read about how you can make your application stand out. working at gsk our people are essential to our success. we focus on building their capabilities, and aim to support and empower them to be the best they can be. students find out about the opportunities we offer for undergraduate students. graduates become a future leader at gsk and help change the face of healthcare. meet our people across our nearly 1,500 strong australian workforce we have engineers, supply chain managers, marketers, chemists, sales representatives, regulatory managers – all bringing their own experiences and expertise. research research open innovation open innovation gsk open innovation program targeting the immune system through open innovation sharing our research trials in people trials in people the race to richer data in clinical trials supporting research gsk award for research excellence gsk award for research excellence apply for the 2018 are previous winners alumni members discovery fast track: australian challenge open innovation our open innovation strategy is designed to promote change beyond gsk by sharing expertise, resources intellectual property and know-how with external researchers and the scientific community in australia and across the globe. sharing our research regardless of whether clinical trials deliver positive or negative results, we are committed to sharing our research and collaborating with others so that we can advance our understanding of medicines and over-the-counter healthcare products. trials in people there are typically four phases to clinical trials. gsk australia is involved in all aspects of these phases. supporting research we are committed to discovering and developing new m
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: gsk.com.au
Last Modified: 02-Jan-2018 06:07:00 UTC
Status: ok
Registrar Name: Corporation Service Company (Australia) Pty Ltd
Registrant: GLAXOSMITHKLINE AUSTRALIA PTY LTD
Registrant ID: ABN 47 100 162 481
Eligibility Type: Company
Registrant Contact ID: MIT680470A162764
Registrant Contact Name: Mal Joseland
Registrant Contact Email: Visit whois.ausregistry.com.au for Web based WhoIs
Tech Contact ID: CSC_12014B29718
Tech Contact Name: Domain Administrator
Tech Contact Email: Visit whois.ausregistry.com.au for Web based WhoIs
Name Server: ns-398.awsdns-49.com
Name Server: ns-904.awsdns-49.net
Name Server: ns-1327.awsdns-37.org
Name Server: ns-2044.awsdns-63.co.uk
DNSSEC: unsigned
REFERRER http://www.aunic.net
REGISTRAR AU-NIC
SERVERS
SERVER au.whois-servers.net
ARGS gsk.com.au
PORT 43
TYPE domain RegrInfo DOMAIN
NAME gsk.com.au
CHANGED 2018-01-02
STATUS ok
SPONSOR Corporation Service Company (Australia) Pty Ltd
NSERVER
NS-398.AWSDNS-49.COM 205.251.193.142
NS-904.AWSDNS-49.NET 205.251.195.136
NS-1327.AWSDNS-37.ORG 205.251.197.47
NS-2044.AWSDNS-63.CO.UK 205.251.199.252
OWNER
ORGANIZATION GLAXOSMITHKLINE AUSTRALIA PTY LTD
HANDLE MIT680470A162764
NAME Mal Joseland
EMAIL Visit whois.ausregistry.com.au for Web based WhoIs
TECH
HANDLE CSC_12014B29718
NAME Domain Administrator
EMAIL Visit whois.ausregistry.com.au for Web based WhoIs
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus
gsk.com.au rapport :
Visitez le site